FDA Inspection 546350 — RNA Bio/Pharma Inc

RNA Bio/Pharma Inc — FEI 3023116

The FDA completed an inspection of RNA Bio/Pharma Inc on Oct 31, 2008 in Chelan, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 31, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chelan, WA (United States)

Citations

IDCFRDescription
122721 CFR 211.67(c)Cleaning/maintenance records not kept
172821 CFR 211.87Retest of approved components/containers/closures
192821 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.